{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:42:13Z","timestamp":1768365733565,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12240-3","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T15:52:51Z","timestamp":1765036371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline medication profile and risk of CYP3A4 mediated drug-drug interactions among COVID-19 hospitalized patients in Spain"],"prefix":"10.1186","volume":"26","author":[{"given":"Alejandro","family":"Mart\u00edn-Quir\u00f3s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Tejerina-Picado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"G\u00fcerri-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Cotarelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Fern\u00e1ndez-Vigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"issue":"1","key":"12240_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360. https:\/\/doi.org\/10.23750\/abm.v91i1.9397.","journal-title":"Acta Biomed"},{"issue":"6","key":"12240_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41591-021-01381-y","volume":"27","author":"V Haldane","year":"2021","unstructured":"Haldane V, De Foo C, Abdalla SM, et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med. 2021;27(6):964\u201380. https:\/\/doi.org\/10.1038\/s41591-021-01381-y.","journal-title":"Nat Med"},{"key":"12240_CR3","unstructured":"Grimm CA, U.S. Department of Health and Human Services. Hospitals reported that the COVID-19 pandemic has significantly strained health care delivery. 2021. Accessed October 11, 2023. https:\/\/oig.hhs.gov\/oei\/reports\/oei-09-21-00140.pdf."},{"key":"12240_CR4","unstructured":"Mathieu E, Ritchie H, Rod\u00e9s-Guirao L, et al. Coronavirus pandemic (COVID-19). Our world in data. Published online March 5, 2020. Accessed October 11, 2023. https:\/\/ourworldindata.org\/excess-mortality-covid."},{"issue":"46","key":"12240_CR5","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.15585\/mmwr.mm7046a5","volume":"70","author":"G French","year":"2021","unstructured":"French G, Hulse M, Nguyen D, et al. Impact of hospital strain on excess deaths during the COVID-19 Pandemic \u2014 United States, July 2020\u2013July 2021. MMWR Morb Mortal Wkly Rep. 2021;70(46):1613\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm7046a5.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"12240_CR6","unstructured":"EMA. COVID-19 medicines. European Medicines Agency. Published June 6. 2023. Accessed October 11, 2023. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/covid-19-medicines."},{"issue":"1","key":"12240_CR7","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1080\/07853890.2022.2133162","volume":"54","author":"S Bellino","year":"2022","unstructured":"Bellino S. COVID-19 treatments approved in the European union and clinical recommendations for the management of non-hospitalized and hospitalized patients. Ann Med. 2022;54(1):2856\u201360. https:\/\/doi.org\/10.1080\/07853890.2022.2133162.","journal-title":"Ann Med"},{"key":"12240_CR8","unstructured":"CDC. Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for healthcare professionals. Centers for disease control and prevention. Published 2023. Accessed October 11. 2023. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html."},{"issue":"4","key":"12240_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/08998280.2000.11927719","volume":"13","author":"CC Ogu","year":"2000","unstructured":"Ogu CC, Maxa JL. Drug interactions due to cytochrome P450. Proc (Bayl Univ Med Cent). 2000;13(4):421\u20133. https:\/\/doi.org\/10.1080\/08998280.2000.11927719.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"12240_CR10","unstructured":"WHO. COVID-19 High risk groups. Published 2023. Accessed October 11. 2023. https:\/\/www.who.int\/westernpacific\/emergencies\/covid-19\/information\/high-risk-groups."},{"issue":"5","key":"12240_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.gaceta.2021.10.004","volume":"36","author":"H V\u00e1squez-Vera","year":"2022","unstructured":"V\u00e1squez-Vera H, Le\u00f3n-G\u00f3mez BB, Borrell C, et al. Inequities in the distribution of COVID-19: an adaptation of who\u2019s conceptual framework. Gac Sanit. 2022;36(5):488\u201392. https:\/\/doi.org\/10.1016\/j.gaceta.2021.10.004.","journal-title":"Gac Sanit"},{"key":"12240_CR12","doi-asserted-by":"publisher","first-page":"jiad324","DOI":"10.1093\/infdis\/jiad324","volume":"11","author":"D Paraskevis","year":"2023","unstructured":"Paraskevis D, Gkova M, Mellou K, et al. Real-world effectiveness of molnupiravir and Nirmatrelvir\/Ritonavir as treatments for COVID-19 in patients at high Risk. The journal of infectious diseases. Published Online August. 2023;11:jiad324. https:\/\/doi.org\/10.1093\/infdis\/jiad324.","journal-title":"Published Online August"},{"key":"12240_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40262-021-00984-5","volume":"60","author":"R Humeniuk","year":"2021","unstructured":"Humeniuk R, Mathias A, Kirby BJ, et al. Pharmacokinetic, Pharmacodynamic, and Drug-Interaction profile of Remdesivir, a SARS-CoV-2 replication inhibitor. Clin Pharmacokinet. 2021;60:569\u201383. https:\/\/doi.org\/10.1007\/s40262-021-00984-5.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"12240_CR14","doi-asserted-by":"publisher","first-page":"e0244779","DOI":"10.1371\/journal.pone.0244779","volume":"16","author":"YF Liu","year":"2021","unstructured":"Liu YF, Zhang Z, Pan XL, et al. The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis. PLoS ONE. 2021;16(1):e0244779. https:\/\/doi.org\/10.1371\/journal.pone.0244779.","journal-title":"PLoS ONE"},{"issue":"1","key":"12240_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14218\/JCTH.2020.00019","volume":"8","author":"J Li","year":"2020","unstructured":"Li J, Fan JG. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020;8(1):13\u20137. https:\/\/doi.org\/10.14218\/JCTH.2020.00019.","journal-title":"J Clin Transl Hepatol"},{"key":"12240_CR16","unstructured":"Girona L. Introduction to pharmacological interactions 1st edition [Introducci\u00f3n a Las Interacciones Farmacol\u00f3gicas 1a Edici\u00f3n]. Sociedad Espa\u00f1ola de Farmacia Hospitalaria; 2018:12\u201365. Accessed January 22, 2024. https:\/\/www.sefh.es\/bibliotecavirtual\/interacc2014\/InteraccionesFarmacoloigicas_pr.pdf."},{"key":"12240_CR17","unstructured":"Larson AM. Drugs and the liver: Metabolism and mechanisms of injury. UpToDate. Published. 2023. Accessed January 22, 2024. https:\/\/www.uptodate.com\/contents\/drugs-and-the-liver-metabolism-and-mechanisms-of-injury?source=history_widget."},{"key":"12240_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.clinthera.2024.08.004","volume":"46","author":"E Mozaffari","year":"2024","unstructured":"Mozaffari E, Chandak A, Ustianowski A, et al. Clin Ther. 2024;46:778\u201384.","journal-title":"Clin Ther"},{"issue":"1","key":"12240_CR19","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1038\/s41598-021-91953-2","volume":"11","author":"MD Cantudo-Cuenca","year":"2021","unstructured":"Cantudo-Cuenca MD, Guti\u00e9rrez-Pizarraya A, Pinilla-Fern\u00e1ndez A, et al. Drug\u2013drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain. Sci Rep. 2021;11(1):12414. https:\/\/doi.org\/10.1038\/s41598-021-91953-2.","journal-title":"Sci Rep"},{"issue":"3","key":"12240_CR20","doi-asserted-by":"publisher","first-page":"e060295","DOI":"10.1136\/bmjopen-2021-060295","volume":"12","author":"C Sirois","year":"2022","unstructured":"Sirois C, Boiteau V, Chiu Y, Gilca R, Simard M. Exploring the associations between polypharmacy and COVID-19-related hospitalisations and deaths: a population-based cohort study among older adults in Quebec, Canada. BMJ Open. 2022;12(3):e060295. https:\/\/doi.org\/10.1136\/bmjopen-2021-060295.","journal-title":"BMJ Open"},{"issue":"2","key":"12240_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","volume":"29","author":"CD Russell","year":"2023","unstructured":"Russell CD, Lone NI, Baillie JK. Comorbidities, Multimorbidity and COVID-19. Nat Med. 2023;29(2):334\u201343. https:\/\/doi.org\/10.1038\/s41591-022-02156-9.","journal-title":"Nat Med"},{"issue":"9836","key":"12240_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of Multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2.","journal-title":"Lancet"},{"issue":"4","key":"12240_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4314\/ahs.v22i4.65","volume":"22","author":"TP Kilit","year":"2022","unstructured":"Kilit TP, \u00d6zyi\u011fit F, Erarslan S, Onba\u015f\u0131 K. Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients. Afr Health Sci. 2022;22(4):597\u2013606. https:\/\/doi.org\/10.4314\/ahs.v22i4.65.","journal-title":"Afr Health Sci"},{"issue":"4","key":"12240_CR24","doi-asserted-by":"publisher","first-page":"e227970","DOI":"10.1001\/jamanetworkopen.2022.7970","volume":"5","author":"V Conti","year":"2022","unstructured":"Conti V, Sellitto C, Torsiello M, et al. Identification of drug interaction adverse events in patients with COVID-19: A systematic review. JAMA Netw Open. 2022;5(4):e227970. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.7970.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"12240_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cpt.2646","volume":"112","author":"C Marzolini","year":"2022","unstructured":"Marzolini C, Kuritzkes DR, Marra F, et al. Recommendations for the management of Drug\u2013Drug interactions between the COVID-19 antiviral Nirmatrelvir\/Ritonavir (Paxlovid) and comedications. Clin Pharmacol Ther. 2022;112(6):1191\u2013200. https:\/\/doi.org\/10.1002\/cpt.2646.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"12240_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.medcli.2020.06.026","volume":"155","author":"D Brandariz-Nu\u00f1ez","year":"2020","unstructured":"Brandariz-Nu\u00f1ez D, Correas-Sanahuja M, Guarc E, Pic\u00f3n R, Garc\u00eda B, Gil R. Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir\/ritonavir. Med Clin (Barc). 2020;155(7):281\u20137. https:\/\/doi.org\/10.1016\/j.medcli.2020.06.026.","journal-title":"Med Clin (Barc)"},{"key":"12240_CR27","unstructured":"Instituto, de Nacional. Estad\u00edstica (INE). https:\/\/www.ine.es."},{"issue":"1","key":"12240_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2020050615","volume":"32","author":"L Chan","year":"2021","unstructured":"Chan L, Chaudhary K, Saha A, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151\u201360. https:\/\/doi.org\/10.1681\/ASN.2020050615.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"12240_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/tropicalmed5020080","volume":"5","author":"T Oyelade","year":"2020","unstructured":"Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in patients with liver and kidney diseases: an early systematic review and Meta-Analysis. Trop Med Infect Dis. 2020;5(2):80. https:\/\/doi.org\/10.3390\/tropicalmed5020080.","journal-title":"Trop Med Infect Dis"},{"issue":"5","key":"12240_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(20)30057-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"12240_CR31","doi-asserted-by":"publisher","first-page":"e2134147","DOI":"10.1001\/jamanetworkopen.2021.34147","volume":"4","author":"S Magesh","year":"2021","unstructured":"Magesh S, John D, Li WT, et al. Disparities in COVID-19 outcomes by Race, Ethnicity, and socioeconomic status: A systematic review and Meta-analysis. JAMA Netw Open. 2021;4(11):e2134147. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.34147.","journal-title":"JAMA Netw Open"},{"key":"12240_CR32","unstructured":"Espa\u00f1a en cifras. 2019. Accessed October 23, 2023. https:\/\/www.ine.es\/prodyser\/espa_cifras\/2019\/10\/."},{"key":"12240_CR33","unstructured":"Country Summary. In: The World Factbook, Central A. 2019. Accessed October 23, 2023. https:\/\/www.cia.gov\/the-world-factbook\/countries\/spain\/summaries\/."},{"issue":"3","key":"12240_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000534250","volume":"41","author":"J Tavares","year":"2023","unstructured":"Tavares J, Figueiredo D, Passos L, Sobrinho L, Souza E, Pedreira L. Atypical presentation of COVID-19 in older adults: A scoping review. Port J Public Health. 2023;41(3):198\u2013217.","journal-title":"Port J Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12240-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:04:37Z","timestamp":1768341877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12240"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12240-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the central Ethics Committee (EC) of the Hospital Clinic I Provincial de Barcelona on February 02, 2023 (reference number HCB\/2023\/0001) and validated by the local EC of all participating sites. The waiver of informed consent for this study was evaluated and approved by the central EC, in accordance with the principles stablished in the Spanish Royal Decree 957\/2020. The study followed the Guidelines for Good Pharmacoepidemiology Practices (GPP), the analysis involving human data were conducted in accordance with the European general data protection regulation (GDPR) and the ethical principles outlined in the Declaration of Helsinki, which ensures the respect, safety, and rights of all participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MC, BM, EFV, and FC are employed by MSD Spain, which may have a financial interest in the study\u2019s outcomes as they could inform future product development. The authors declare no other conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}